Human T2R38 Bitter Taste Receptor Expression and COVID-19: From Immunity  to Prognosis

Lakshmi Deepak  Bethineedi; Hediyeh  Baghsheikhi; Afsaneh  Soltani; Zahedeh  Mafi; Noosha  Samieefar; Shaikh  Sanjid Seraj; Mohammad Amin  Khazeei Tabari

doi:10.18502/ajmb.v15i2.12022

Lakshmi Deepak Bethineedi Andhra Medical College, Visakhapatnam, Andhra Pradesh, India
Hediyeh Baghsheikhi Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Afsaneh Soltani Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Zahedeh Mafi Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Noosha Samieefar Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Shaikh Sanjid Seraj Walsall Healthcare NHS Trust, Walsall Manor Hospital, Walsall, United Kingdom
Mohammad Amin Khazeei Tabari Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran

DOI: https://doi.org/10.18502/ajmb.v15i2.12022

Keywords: Bitter taste receptors (T2Rs), Coronavirus disease, COVID-19, Infection, T2R38

Abstract

Background: Bitter taste-sensing type 2 receptor (T2Rs or TAS2Rs) found on ciliated epithelial cells and solitary chemosensory cells have a role in respiratory tract immunity. T2Rs have shown protection against SARS-CoV-2 by enhancing the innate immune response. The purpose of this review is to outline the current sphere of knowledge regarding this association.

Methods: A narrative review of the literature was done by searching (T2R38 OR bitter taste receptor) AND (COVID-19 OR SARS-CoV-2) keywords in PubMed and google scholar.

Results: T2R38, an isoform of T2Rs encoded by the TAS2R38 gene, may have a potential association between phenotypic expression of T2R38 and prognosis of COVID-19. Current studies suggest that due to different genotypes and widespread distributions of T2Rs within the respiratory tract and their role in innate immunity, treatment protocols for COVID-19 and other respiratory diseases may change accordingly. Based on the phenotypic expression of T2R38, it varies in innate immunity and host response to respiratory infection, systemic symptoms and hospitalization.

Conclusion: This review reveals that patients’ innate immune response to SARS-COV-2 could be influenced by T2R38 receptor allelic variations.